Clinical trial

Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma

NCT01446497

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE4

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2011-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Normal Tension Glaucomaunresolved

Interventions

Brimonidine/Timolol mixed combinationDRUG

TimololDRUG · verified · RxNorm: timolol

Sponsors & collaborators

Seoul National University Hospitallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01446497 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.